Carina Biotech to Participate in Three Upcoming Conferences
ADELAIDE, Australia, May 24, 2023 (GLOBE NEWSWIRE) -- Carina Biotech (Carina), a cell therapy immuno-oncology company, today announced that the management team will participate in the three upcoming conferences as follows:
About Carina Biotech
Using its proprietary chemokine receptor platform, Carina aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects.
Carina also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients.
For more information please contact:
ITEXPO#TECHSUPERSHOW Expo Hall Open
IoT at the Branch Office or Storeâ€¦How to Achieve Immediate ROI from Wireless Failover
UCaaS and MSPs: Driving Collaboration, Productivity, and Customer Experience